Public signalCompany raiseAuto-indexed · Unverified
AgNovos Bioscience, Inc. raised $13.4M
AgNovos Bioscience, Inc.· ROCKVILLE, US· Other Health Care· Filed Mar 12, 2024
AgNovos Bioscience, Inc. reported raising capital. Based in ROCKVILLE, MARYLAND, US. First sale reported 2023-12-20. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$13.4M
Confidence90%
Raised
$13.4M
Investors
8
Incorporated
2022
Jurisdiction
DELAWARE
On the record
- Location
- ROCKVILLE, US
- Sector
- Other Health Care
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $13.4M
- Target amount
- $13.4M
- Filing date
- Mar 12, 2024
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Filing details
- Jurisdiction of incorporation
- DELAWARE
- Year incorporated
- 2022
- Industry group
- Other Health Care
- Number of investors
- 8
- Includes non-accredited investors
- No
- Revenue range
- Decline to Disclose
- Total offering amount
- $13.4M
- Amendment
- No
People named on this filing
Officers, directors, managers and entities listed in the public filing.
Adam Lowe
Executive Officer
Rockville, US
Bill Beasley
Executive Officer
Rockville, US
Chris Gegeyls
Executive Officer
Rockville, US
David Stiller
Director
Rockville, US
Dawn Svoronos
Director
Rockville, US
Ellen Zane
Director
Rockville, US
Falk Dukatz
Executive Officer
Rockville, US
James Barry
Director
Rockville, US
James G. Howe
Executive Officer
Rockville, US
James Pilachowski
Executive Officer
Rockville, US
James Shimp
Executive Officer
Rockville, US
James T. Howe
Executive Officer
Rockville, US
Jarrett Waldner
Executive Officer
Rockville, US
Jason Foley
Executive Officer
Rockville, US
Michael Schmertzler
Director
Rockville, US
Nick Valeriani
Director
Rockville, US
Robert Stiller
Director
Rockville, US
Stephanie Kladakis
Executive Officer
Rockville, US
Sources & provenance
“Operating company sold 13,377,366 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Mar 12, 2024. Details beyond the filing have not been verified.
Tags
USCompanyOther Health Care$10M – $100MCompany Raise
Are you associated with AgNovos Bioscience, Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record